Building on the success in 2019, the 2nd Longevity Therapeutics 2020 Summit
will once again return to San Francisco. As the only industry-led and end-to-end longevity meeting, we will hear success stories in the last 12 months and explore what’s next to help you accelerate your pipeline into clinic! Uniting biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative anti-aging drugs and overcome key preclinical, translational, clinical and regulatory challenges going forward.
Find our more: https://ter.li/v98eiz